Department of Clinical Sciences, High Point University Fred Wilson School of Pharmacy, High Point, NC.
Department of Pharmacy, Vidant Medical Center, Greenville, NC.
Am J Med. 2020 Jun;133(6):675-678. doi: 10.1016/j.amjmed.2020.01.030. Epub 2020 Mar 5.
In 2019, the US Food and Drug Administration (FDA) approved 48 novel drugs. Thirty of the 48 (62.5%) novel drug approvals were reviewed and approved through an expedited review pathway while 20 of the 48 (41.7%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2019.
2019 年，美国食品和药物管理局（FDA）批准了 48 种新的药物。其中 48 种新药中有 30 种（62.5%）通过加速审查途径进行了审查和批准，而 48 种中有 20 种（41.7%）用于治疗罕见疾病。本综述包括了 2019 年 FDA 批准的新药物的概述。
